Venaxis, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 141 62 282 439
Cost of Revenue 21 1 16 358
Gross Profit 119 62 265 81
Operating Expenses
Research and Development 6,706 3,838 5,666 6,112
Sales, General and Admin. 5,517 5,185 5,575 7,418
Non-Recurring Items - - - -
Other - - - -
Operating Income (12,103) (8,962) (10,976) (13,450)
Income From Continuing Operations
Add'l Income/Expense Items 51 (2) 943 245
Earnings Before Interest and Tax (12,053) (8,964) (10,033) (13,205)
Interest Expense 96 249 181 133
Earnings Before Tax (12,149) (9,212) (10,214) (13,338)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (12,149) (9,212) (10,214) (13,338)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (12,149) (9,212) (10,214) (13,338)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (12,149) (9,212) (10,214) (13,338)